New Business Hours - Effective July 1, 2024
Monday - Friday 8:30am to 7:00pm
Saturday - 8:30am to 4:00pm
Sunday - Closed

Get Healthy!

Results for search "Diabetes: Drugs".

Health News Results - 72

Wegovy Helps Those With Both Diabetes, Heart Failure: Study

For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.

In the study, published Saturday in the New England Journal of Medicine, researchers reported that the drug helped people with typ...

FDA Clears First OTC Continuous Blood Glucose Monitor

The U.S. Food and Drug Administration on Tuesday approved the country's first continuous glucose monitor for type 2 diabetes.

The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2 diabetes but do not take insulin, according to the agency.

Also known as CGMs, these monitors consist of tiny sensors that pr...

FDA Looking Into New Risks With Popular Weight-Loss Drugs

The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.

In a quarterly report...

More Americans Will Only Have to Pay $35 a Month for Insulin in 2024

Managing diabetes will be a less expensive proposition for more Americans in 2024.

Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drugmakers are also drastically lowering the list prices for their insulin pr...

Newer Diabetes Meds Might Not Work as Well in Black Patients

New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people.

Whether the medications -- called sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucogen-like peptide 1 receptor agonists (GLP1-Ras) -- actually have less benefit for Black patients or whether the small sample s...

Diabetes Drug Maker Sues Over Compounded Versions of Mounjaro

Another diabetes drug maker is taking legal action against businesses in several states, alleging that they're “fraudulently claiming” that their compounded products are the same as its medication.

This time, it's Eli Lilly suing certain medical spas, wellness centers and compounding pharmacies over its medication Mounjaro.

Mounjaro contains the active ingredient tirzepatide an...

Amid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024

As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.

The new plan extends by months existing restrictions and means patients who are not already taking the medication will have to wait to start.

“We are going to continue to supply the marke...

Could Metformin Help Seniors Bounce Back After Surgery?

The diabetes drug metformin might also benefit older patients after an injury or illness, a small study suggests.

Researchers found that metformin -- a drug that has been around for more than a half-century to regulate blood sugar -- may have a different ability: It can target senescent cells that affect muscle function. These "zombie-like" cells release chemicals linked with inflammation...

Weekly Insulin Shot Could Be a Game Changer for Those With Type 2 Diabetes

People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required.

A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trial results show.

Icodec now awaits approval by the U.S. Food and Drug Administration based on these results, ...

Diabetes Medications: Choosing Which Ones Are Best for You

You have been diagnosed with type 2 diabetes. What are your medication options?

That depends on what type of diabetes you have and what risk factors you carry.

In type 2 diabetes, the body becomes resistant to the insulin and the pancreas has to make more. Insulin resistance can be caused by obesity, lack of exercise, medication, stress or hereditary factors. Initially, the pancreas...

Taking Ozempic, Wegovy? Stop Before Surgery, Anesthesiologists Say

The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.

Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestion to slow down, which decreases hunger and reduces how much people eat.

That food left in the...

New Drugs Line Up to Challenge Ozempic, Wegovy for Weight Loss

After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed.

Other pharmaceutical giants took notice, and over the past weekend the results of multiple clinical trials from would-be competitors were unveiled at this year's annual meeting of the American Diabetes Association (A...

Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic

The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration.

In a sta...

Diabetes Med Metformin Might Help Prevent Long COVID

A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows.

Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battling their infection, the researchers reported.

The results were even more dramatic if COVID-19 patients began taking metformin soon after infection. Starting on the drug w...

Head-to-Head Study Finds Which Diabetes Meds Are Best for the Heart

There are many medications for type 2 diabetes, but one class may stand out for protecting the heart, a new study suggests.

The study, of thousands of U.S. veterans with diabetes, found that those who added drugs called GLP-1 receptor agonists to their usual regimen were somewhat less likely to suffer a first-time heart attack or stroke in coming years.

That was in comparison to vet...

Eli Lilly to Slash Insulin Prices, Cap Monthly Out-of-Pocket Costs at $35

More Americans will soon be paying less for their insulin.

Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70% and cap out-of-pocket costs at $35 a month.

"While the current health care system provides access to insulin for most people with diabetes, it still does not provide affordable insulin for everyone, and that needs to change," E...

Too Few Americans With Diabetes Are Getting Recommended Meds

Most Americans with type 2 diabetes are candidates for newer, pricey medications, but few are getting them, a new government study shows.

Researchers found that of U.S. adults with the blood sugar disease, over 80% could stand to benefit from the medications, based on recommendations from the American Diabetes Association (ADA). But only 10% of those people were actually taking the drugs ...

Type 1 Diabetes and Use of 'Off-Label' Drugs: Benefits, but Concerns, Too

While people with type 1 diabetes can see some benefit from newer medications prescribed off-label, there is also risk, and these patients should be monitored closely, according to a new study.

Type 1 diabetes is universally treated with insulin injections, but only about one-fifth of patients achieve blood sugar control with it,

  • Cara Murez HealthDay Reporter
  • |
  • February 20, 2023
  • |
  • Full Page
  • Diabetes Med Ozempic in Short Supply as Americans Use It for Weight Loss

    Elon Musk swears by the weight-loss drug Wegovy, and Kim Kardashian is rumored to have used it to shed 16 pounds in three weeks to squeeze into a vintage gown once worn by Marylin Monroe.

    But the intense public demand for Wegovy has triggered a shortage of the diabetes version of the injectable medication, known as Ozempic. That's leaving patients with the blood sugar disease in a real bi...

    Insulin Pumps Ease Diabetes Care. So Why Are Black Patients Less Likely to Get One?

    Insulin pumps can help folks with type 1 diabetes get better control of their disease and minimize how often they inject insulin, and use of the devices has taken off in the past 20 years.

    That's the good news from a new study.

    The not-so-great news is that a large gap in wh...

    Cats Now Have an FDA-Approved Pill to Treat Their Diabetes

    Owners whose cats have diabetes now have a new option to care for the condition in their otherwise healthy pets.

    The U.S. Food and Drug Administration on Thursday approved the first pill to improve control of diabetes in some cats.

    The drug, call...

    Diabetes Drug Metformin Might Keep Severe COVID Away

    A century-old diabetes drug seems to help keep high-risk COVID-19 patients from falling deathly ill, a new study reports.

    Metformin reduced the risk of death from COVID-19 by 44% in a group of diabetics who were taking the drug when they became infected with the coronavirus, according t...

    California's Plan to Make Low-Priced Insulin Could Be Example for Nation

    California's plan to manufacture its own insulin could be a huge money-saver for state residents with diabetes -- and possibly be a model for other states, according to experts.

    Earlier this year, California announced an initiative to bring its own insulin products to market, in response to the steep costs of the lifesaving drug in the United States.

    And if it's successful, it will ...

    Certain Class of Diabetes Meds Could Cut Dementia Risk

    An older class of type 2 diabetes drugs known as thiazolidinediones, or TZDs, may protect you from dementia down the road, according to new research.

    Thiazolidinediones, also known as glitazones, cut dementia risk by 22% among folks at high risk who also had mild or moderate type 2 diabetes when they took these me...

    Over a Million Americans Are Rationing Insulin Due to High Cost

    More than 1 million Americans with diabetes have to ration lifesaving insulin because they can't afford it, a new study shows.

    Many people delayed picking up their insulin prescription, while others took lower doses than they needed, researchers found.

    Exp...

    Big Studies Test Effectiveness of Common Diabetes Meds

    Two common diabetes medications seem to outperform two others when it comes to controlling blood sugar levels, a large U.S. trial has found.

    The trial of more than 5,000 people with type 2 diabetes found that two injection medications -- a long-acting insulin and

  • Amy Norton HealthDay Reporter
  • |
  • September 22, 2022
  • |
  • Full Page
  • Experimental Insulin-in-a-Pill Shows Promise in Rat Study

    People with type 1 diabetes who need to inject insulin a few times a day could eventually be switching to an easier-to-take tablet that dissolves inside the cheek.

    Canadian researchers working with rodents report they have created an insulin that could be taken in pill form without most of bein...

    Common Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says

    The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administration announced this week.

    Despite the discovery that Nitroso-STG-19 (NTTP) had been found in some samples of the drug, known generically as

  • By Cara Murez HealthDay Reporter
  • |
  • August 12, 2022
  • |
  • Full Page
  • Rise in Birth Defects for Babies Whose Fathers Took Common Diabetes Drug

    Babies born to fathers who were taking the common diabetes drug metformin may have a slightly increased risk of certain birth defects, a large new study suggests.

    Among over 1 million babies born in Denmark, just over 3% had a birth defect of some kind. But that rate was roughly 5% among babies whose fathers ...

    When Will Americans With Diabetes Get Relief From High Insulin Prices?

    Katherine Stewart, 16, must take six to 10 insulin shots a day to properly manage her type 1 diabetes.

    Her Highland, Utah, family pays $500 a month out of pocket for her insulin. Before they meet their insurance's deductible, they shell out the cash price of nearly $2,000 a month.

    Now Stewart is preparing to leave the nest, and she doesn't know how she'll be able to afford it.

    Osteoporosis Drug May Keep Type 2 Diabetes at Bay

    A drug widely used to treat osteoporosis might reduce the risk of type 2 diabetes, a new study suggests.

    Taking the drug alendronate (Fosamax) for at least eight years could potentially reduce a person's risk of type 2 diabetes by more than half, compared to people never prescribed the drug, according to findings presented Sunday at the annual meeting of the European Association for the S...

    Diabetes Drug Might Help Women With Preeclampsia Prolong Their Pregnancy

    Metformin, a commonly prescribed diabetes drug, may help stave off preterm birth among women who develop pregnancy-related high blood pressure.

    Preeclampsia is marked by a sudden spike in blood pressure, protein in urine, or other problems during pregnancy. Preterm preeclampsia occurs between 26 and 32 weeks of pregnancy and often leads to early delivery, putting babies at risk. Preemies ...

    Some Diabetes Meds Might Also Lower Alzheimer's Risk

    Older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills, a new study suggests.

    Researchers in South Korea found that among older people who'd been having memory issues, those using diabetes drugs called DDP-4 inhibitors typically showed a slower progression in those symptoms over the next few years. That was compared with both diabetes-fre...

    When Deductibles Rise, More Diabetes Patients Skip Their Meds

    As many Americans know, today's health insurance plans often come with high deductibles. Those out-of-pocket costs could cause harm: New research shows that 20% of people who have diabetes and high-deductible health plans regularly skip their medications.

    Not keeping up with your diabetes medications comes with the potential risk of an emergency room visit or a hospitalization.

    FDA OKs Automatic Use of a Cheaper Generic  Insulin

    U.S. pharmacists will now be able to automatically substitute a cheaper biosimilar for a more expensive brand-name insulin, the U.S Food and Drug Administration announced Wednesday.

    The agency's approval of an "interchangeable" biosimilar could save diabetics and health plans millions each year, the Associated Press reported. Until now, doctors have had to specifically prescribe ...

    Walmart to Offer Low-Priced Insulin

    TUESDAY, June 29, 2021 (HealthDay News) --Walmart said Tuesday that it will start selling its own private brand of insulin at much lower prices than competing products.

    Insulin prices have skyrocketed in recent years, making it unaffordable for some Americans with diabetes, according to CBS News.

    "We know many people with diabetes struggle to manage the financial burden of ...

    Which Blood Sugar Meds Work Best Against Type 2 Diabetes?

    You have type 2 diabetes, and you are already taking an old standby drug, metformin. But you still need help controlling your blood sugar levels. Which medication would be the best?

    New research pitted several diabetes drugs against each other and came up with an answer: The diabetes drugs Lantus and Victoza were better at controlling blood sugar over time than Amaryl or Januvia.

    "W...

    Weekly Injected Drug Could Boost Outcomes for Patients With Type 2 Diabetes

    People with type 2 diabetes face heightened risks for heart attack and stroke, as well as progressive kidney disease. But a new once-a-week injected drug called efpeglenatide could greatly reduce their odds for those outcomes, new research shows.

    The clinical trial was conducted in over 28 nations and involved more than 4,000 patients with type 2 diabetes.

    Over two years, patients ...

    Poorly Managed Diabetes Raises Odds for More Severe COVID

    Hospitalized patients with diabetes who hadn't been taking their medication had more severe cases of COVID-19, a new study shows.

    "Our results highlight the importance of assessing, monitoring and controlling blood glucose [sugar] in hospitalized COVID-19 patients from the start," said study author Sudip Bajpeyi, associate professor of kinesiology at the University of Texas at El Paso. H...

    America Is Losing the War Against Diabetes

    After years of improvement, Americans with diabetes may be losing some ground in controlling the condition, a new government-funded study shows.

    Researchers found that between 1999 and the early 2010s, U.S. adults with diabetes made substantial gains: A growing percentage had their blood sugar, blood pressure and cholesterol down to recommended levels.

    Since then, the picture has ch...

    Could Certain Diabetes Drugs Fight Asthma, Too?

    Researchers have discovered that when patients who have type 2 diabetes and asthma take a certain class of medication to control their blood sugar, their asthma symptoms also improved.

    Not only could this help diabetes patients who may have less asthma control on asthma medicines, but it could potentially open up new treatment options for those who don't have diabetes.

    The study sho...

    Common Type 2 Diabetes Meds Won't Raise Breast Cancer Risk: Study

    Widely used diabetes and obesity drugs don't increase the risk of breast cancer, a new study indicates.

    The drugs -- called glucagon like peptide-1 receptor agonists or GLP-1 RAs for short -- are effective in treating type 2 diabetes and obesity and in reducing heart disease. But some previous studies have suggested a possible link between them and breast cancer.

    GLP-1RAs include al...

    Could a Drug Prevent Type 1 Diabetes in Those at Risk?

    Just two weeks of treatment with an experimental drug can delay the onset of type 1 diabetes by several years, researchers report.

    The drug, called teplizumab, is already under review by the U.S. Food and Drug Administration based on earlier evidence of its effectiveness.

    If it gets the green light, it would become the first drug approved for delaying type 1 diabetes in high-risk pe...

    Patients With Diabetes Need More Counseling on Low Blood Sugar

    Doctors need to do a better job of discussing low blood sugar with patients who take high-risk diabetes medications such as insulin, researchers say.

    Low blood sugar (hypoglycemia) is the most common serious side effect of diabetes treatment. Severe cases can lead to falls, emergency department visits, and may increase the risk of stroke and death.

    "For patients to have safe diabete...

    Insulin May Not Need Refrigeration, Freeing Up Its Use in Poorer Nations

    Researchers report that insulin can be stored at less-cold temperatures than previously known, potentially simplifying diabetes care for people in warmer regions that have fewer resources.

    Researchers from Doctors Without Borders and the University of Geneva tested insulin storage in real conditions ranging from 77 to 98.6 degrees Fahrenheit for four weeks -- the time it typically takes t...

    Type 2 Diabetes Drug Metformin Could Help Prevent Some Breast Cancers

    Women with type 2 diabetes may be more likely to develop breast cancer, but taking the diabetes drug metformin appears to reduce their risk for the most common type, new research finds.

    Compared to women without diabetes, risk for estrogen-positive breast cancer was 38% lower among women with type 2 diabetes who had used metformin for 10 years or more.

    Metformin did not protect agai...

    Common Diabetes Meds Tied to Serious COVID-19 Complication

    Diabetics who've contracted COVID-19 should suspend their use of a class of common diabetes drugs known as sodium-glucose co-transporter 2 inhibitors (SGLT2i), new research warns.

    People using these medications for diabetes are at risk of a potentially fatal complication called diabetic ketoacidosis (DKA), and it now appears that risk increases even more if they become sick with COVID-19,...

    Diabetes Drug Metformin May Protect the Aging Brain

    A common type 2 diabetes drug called metformin may have an unexpected, but positive, side effect: New research suggests that people taking the drug appear to have significantly slower declines in thinking and memory as they age.

    "Our six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use and slower cognitive [mental] decline and lower deme...

    Once-a-Week Insulin for Type 2 Diabetes Shows Promise in Early Trial

    Type 2 diabetes can be tough to control without medication. But for some people, the thought of daily shots makes them delay or avoid starting insulin therapy.

    Now, new research offers some hope for those insulin avoiders -- a once-a-week insulin injection may someday replace daily shots.

    A phase 2 trial compared the new weekly insulin, called icodec, to the commonly used i...

    Pandemic Means Financial Hardship for Many With Diabetes

    People with diabetes face a higher risk of developing complications from COVID-19, but a new survey reports they have also suffered more economic fallout from the pandemic.

    In June, 18% of people with diabetes were out of work compared to 12% of the general population. And one-third of people with diabetes have lost at least some income since the pandemic began versus about 2...